Below you will find the materials for the 2017 Fall Pharmaceutical EHS Counsel Roundtable, held on Tuesday, November 7 in Washington, DC.
- China Update: Recent and Anticipated EHS Requirements Impacting Pharmaceutical Manufacturing and Supply Chains
- Expanding EPR Laws Targeting Unused Medicines and Medical Devices
- Responsible Sourcing: Due Diligence and Disclosure in Global Supply Chains
- Future of Superfund: New EPA Initiatives and Hurdles to Implementation
- Other Resources:
About the Roundtable
Launched in 2007, the Pharmaceutical EHS Counsel Roundtable provides an opportunity for in-house EHS counsel at leading pharmaceutical companies to meet and discuss emerging EHS legal issues pertaining to pharmaceutical products and operations in the U.S. and in key markets worldwide. The Roundtable also affords participants an opportunity to discuss compliance approaches, opportunities to reduce legal risks, and EHS aspects of supply chain management.